טוען...
Anti-Ebola therapies based on monoclonal antibodies: Current state and challenges ahead
The 2014 Ebola outbreak, the largest recorded, took us largely unprepared, with no available vaccine or specific treatment. In this context, the World Health Organization (WHO) declared that the humanitarian use of experimental therapies against Ebola Virus (EBOV) is ethical. In particular, an exper...
שמור ב:
| הוצא לאור ב: | Crit Rev Biotechnol |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5568563/ https://ncbi.nlm.nih.gov/pubmed/26611830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/07388551.2015.1114465 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|